LFG
INBX icon

Larson Financial Group’s Inhibrx INBX Stock Holding History

Larson Financial Group’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$95 Buy
+1
New +$100 ﹤0.01% 3655
2024
Q4 		– Sell
-581
Closed -$9.1K – 2832
2024
Q3 		$9.1K Buy
+581
New +$8.16K ﹤0.01% 1510

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Larson Financial Group's INBX Position: Q2 2026 in Review

Larson Financial Group opened a new position in Inhibrx (INBX) in Q2 2026: 1 share worth $95. The stake represents ﹤0.01% of the portfolio and ranks #3655 among its holdings. This is a return to the name: Larson Financial Group previously reported a position in INBX as recently as Q3 2024.

Larson Financial Group first reported a position in INBX in Q3 2024 and has held it in 2 quarters since. The position peaked at $9.1K in Q3 2024. 162 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Larson Financial Group held 1 share of Inhibrx worth $95 as of Q2 2026.
  • Inhibrx was a new Larson Financial Group position in Q2 2026.
  • Inhibrx made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #3655 holding.
  • Larson Financial Group first reported a position in Inhibrx in Q3 2024 and has held it in 2 quarters since.
  • Larson Financial Group's Inhibrx position peaked at $9.1K in Q3 2024.
  • 162 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.